Company: EUDAW
Filing Date: 2025-06-24
Form Type: 424B5
Source: 0001641172-25-016185
Chunk: 11

Company: EUDA Health Holdings Ltd
Filing Date: 2025-06-24
Form: 424B5
Chunk 11
---
 as they continue to own a significant amount of our equity, these holders will be able to strongly influence or effectively control our decisions.

The Company has a part-time Interim Chief Financial Officer and the management team has limited experience working together.

Effective September 3, 2024, Ms. Vivian Tay has served as the Company’s part-time Interim Chief Financial Officer while the Company searches for a full-time successor CFO. Ms. Tay is currently the Accounts Director at 8i Enterprises Pte. Ltd., of which Mr. Meng Dong (James) Tan is the sole shareholder and director. Mr. Tan is a significant shareholder of the Company, holding approximately 25% of the currently issued and outstanding ordinary shares of the Company. The Company’s management team is currently comprised of Mr. Alfred Lim, the Chief Executive Officer and Executive Director, and Ms. Vivian Tay, the Interim Chief Financial Officer. The Company’s management team has limited experience working together, managing a publicly traded company, interacting with public company investors, and complying with the increasingly complex laws, rules and regulations that govern U.S. public companies. Loss of any one of them would likely harm the Company’s ability to implement its business strategy and respond to the rapidly changing market conditions in which it operates. The Company cannot assure you that management will succeed in working together as a team. In the event that the Company is unable to retain or integrate its management team, its business, prospects, and operations could be adversely impacted.

EUDA and our independent registered public accounting firm identified material weakness in the Company’s internal control over financial reporting, and if EUDA is unable to achieve and maintain effective internal control over financial reporting, this could have a material adverse effect on our business.

The Company produces our consolidated financial statements in accordance with the requirements of U.S. GAAP. Effective internal controls are necessary for EUDA to provide reliable financial reports to help mitigate the risk of fraud and to operate as a publicly traded company. Prior to the Business Combination, EUDA was a private company with limited accounting personnel and other resources with which to address internal controls and procedures. EUDA and our independent registered public accounting firm identified material weaknesses in the Company’s internal controls over financial reporting in connection with the audits of EUDA’s financial statements for the year ended December 31, 2024 and 2023. A “material weakness” is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or